{"entity":{"type":"insider","cik":"0001281153","url":"/insider/0001281153","json_url":"/insider/0001281153.json","name":"FHM IV LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":942,"n_filings":41,"first":"2004-02-24","last":"2008-03-10","span_basis":"filed_date"},"name_variants":[{"name":"FHM IV LP","source":"filing","n_filings":41,"first_seen":"2004-02-24","last_seen":"2008-03-10"}],"transactions":[{"id":3484155,"accession":"0001144204-08-014370","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001144204-08-014370","line_url":"/filing/0001144204-08-014370","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FRAZIER AFFILIATES IV LP; FHM IV LP; FHM V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4740.0,"shares_display":"4,740","price_per_share":10.273457805907173,"price_display":"10.27","price_state":"stated","total_value":48696.19,"total_display":"48,696.19","total_whole":"48,696","shares_owned_after":919364.0,"shares_owned_after_display":"919,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-10","filed_date":"2008-03-10","scope":"insider","n_lines":17},{"id":2678817,"accession":"0001144204-08-014369","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":760.0,"shares_display":"760","price_per_share":10.0675,"price_display":"10.07","price_state":"stated","total_value":7651.3,"total_display":"7,651.30","total_whole":"7,651","shares_owned_after":915764.0,"shares_owned_after_display":"915,764","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-10","filed_date":"2008-03-10","scope":"insider","n_lines":5},{"id":2678791,"accession":"0001144204-08-014369","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001144204-08-014369","line_url":"/filing/0001144204-08-014369","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"Frazier Healthcare V, LP; FHM V, LLC; FRAZIER HEALTHCARE IV LP; FHM V, LP; FHM IV LP; FRAZIER AFFILIATES IV LP","owner_display_name":"Frazier Healthcare V, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22146.0,"shares_display":"22,146","price_per_share":10.011879684818929,"price_display":"10.01","price_state":"stated","total_value":221723.0875,"total_display":"221,723.09","total_whole":"221,723","shares_owned_after":913064.0,"shares_owned_after_display":"913,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-10","scope":"insider","n_lines":25},{"id":3890045,"accession":"0001144204-08-013606","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001144204-08-013606","line_url":"/filing/0001144204-08-013606#line-30","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"FHM IV LP; Frazier Healthcare V, LP; FHM V, LLC; FRAZIER AFFILIATES IV LP; FRAZIER HEALTHCARE IV LP; FHM V, LP","owner_display_name":"FHM IV LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":9.64,"price_display":"9.64","price_state":"stated","total_value":28920.0,"total_display":"28,920.00","total_whole":"28,920","shares_owned_after":846018.0,"shares_owned_after_display":"846,018","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-05","filed_date":"2008-03-05","scope":"insider"},{"id":3890041,"accession":"0001144204-08-013606","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001144204-08-013606","line_url":"/filing/0001144204-08-013606#line-29","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"FHM IV LP; Frazier Healthcare V, LP; FHM V, LLC; FRAZIER AFFILIATES IV LP; FRAZIER HEALTHCARE IV LP; FHM V, LP","owner_display_name":"FHM IV LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2900.0,"shares_display":"2,900","price_per_share":9.655,"price_display":"9.66","price_state":"stated","total_value":27999.5,"total_display":"27,999.50","total_whole":"28,000","shares_owned_after":849018.0,"shares_owned_after_display":"849,018","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-05","filed_date":"2008-03-05","scope":"insider"},{"id":3890039,"accession":"0001144204-08-013606","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001144204-08-013606","line_url":"/filing/0001144204-08-013606#line-28","is_derivative":false,"issuer_cik":"0001140366","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001140366","owner_cik":null,"owner_name":"FHM IV LP; Frazier Healthcare V, LP; FHM V, LLC; FRAZIER AFFILIATES IV LP; FRAZIER HEALTHCARE IV LP; FHM V, LP","owner_display_name":"FHM IV LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2800.0,"shares_display":"2,800","price_per_share":9.66,"price_display":"9.66","price_state":"stated","total_value":27048.0,"total_display":"27,048.00","total_whole":"27,048","shares_owned_after":851818.0,"shares_owned_after_display":"851,818","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-05","filed_date":"2008-03-05","scope":"insider"}],"collapsed":true,"next_cursor":"2008-03-05|3890039","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS INC","url":"/issuer/0001178879","role":"Ten percent owner","n_filings":39,"first_seen":"2007-06-29","last_seen":"2008-03-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001298521","name":"Trubion Pharmaceuticals, Inc","url":"/issuer/0001298521","role":"Ten percent owner","n_filings":1,"first_seen":"2006-10-20","last_seen":"2006-10-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001034842","name":"RIGEL PHARMACEUTICALS INC","url":"/issuer/0001034842","role":"Ten percent owner","n_filings":1,"first_seen":"2004-02-24","last_seen":"2004-02-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001281153","retrieved_at":"2026-08-23T04:43:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}